Cytosar 500 mg Injection

Injection de Cytosar 500 mg contains Cytarabine, a potent chemotherapy medication used to treat various types of cancer. Cytarabine is an antimetabolite that works by interfering with DNA synthesis, thus inhibiting the growth and proliferation of cancer cells. It is particularly effective against certain types of leukemia, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), as well as lymphomas.

The typical dosage and administration of Injection de Cytosar 500 mg are determined by a qualified healthcare professional based on the specific type and stage of cancer, as well as the patient’s overall health. It is usually administered intravenously or subcutaneously.

Common side effects associated with Cytarabine therapy can include bone marrow suppression (leading to decreased white blood cells, red blood cells, and platelets), nausea, vomiting, diarrhea, hair loss, and mouth sores. More serious side effects may occur, and patients should report any unusual symptoms to their doctor immediately.

Injection de Cytosar 500 mg should be stored at room temperature, protected from light, and kept out of reach of children. It is crucial to follow your doctor’s instructions precisely when using this medication.